Senseonics Holdings, Inc. (NYSE:SENS) Receives $22.70 Average Target Price from Analysts

Senseonics Holdings, Inc. (NYSE:SENS) has been given an average rating of “Buy” by the six analysts that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating, three have issued a buy rating and two have given a strong buy rating to the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $22.70.

Several research analysts recently commented on SENS shares. HC Wainwright boosted their price objective on shares of Senseonics to $18.50 and gave the stock a “buy” rating in a research note on Thursday, November 6th. Barclays reaffirmed an “overweight” rating and issued a $31.00 price target (up from $1.50) on shares of Senseonics in a report on Wednesday, November 5th. Finally, TD Cowen reiterated a “buy” rating on shares of Senseonics in a report on Thursday, January 8th.

Institutional Investors Weigh In On Senseonics

Several institutional investors have recently added to or reduced their stakes in SENS. First Light Asset Management LLC increased its holdings in shares of Senseonics by 666.7% during the second quarter. First Light Asset Management LLC now owns 35,708,124 shares of the company’s stock valued at $17,011,000 after acquiring an additional 31,050,619 shares in the last quarter. Vanguard Group Inc. grew its position in Senseonics by 2.2% during the 3rd quarter. Vanguard Group Inc. now owns 34,219,484 shares of the company’s stock worth $14,920,000 after purchasing an additional 749,453 shares during the last quarter. Geode Capital Management LLC increased its stake in Senseonics by 26.6% during the 2nd quarter. Geode Capital Management LLC now owns 8,701,129 shares of the company’s stock valued at $4,147,000 after purchasing an additional 1,828,302 shares in the last quarter. Hood River Capital Management LLC purchased a new position in shares of Senseonics in the second quarter worth $3,775,000. Finally, Masters Capital Management LLC lifted its stake in shares of Senseonics by 11.1% during the third quarter. Masters Capital Management LLC now owns 5,000,000 shares of the company’s stock worth $2,179,000 after buying an additional 500,000 shares during the period. Institutional investors and hedge funds own 12.36% of the company’s stock.

Senseonics Price Performance

Shares of SENS stock opened at $8.16 on Wednesday. The stock’s 50-day moving average is $6.94 and its 200 day moving average is $7.62. Senseonics has a 1-year low of $5.25 and a 1-year high of $22.10. The company has a debt-to-equity ratio of 59.17, a current ratio of 2.47 and a quick ratio of 2.38. The company has a market cap of $333.41 million, a P/E ratio of -62.77 and a beta of 0.99.

About Senseonics

Senseonics Holdings, Inc is a medical technology company focused on the development and commercialization of innovative continuous glucose monitoring (CGM) systems for people with diabetes. Since its founding in 2011 and headquartered in Germantown, Maryland, the company has pioneered an implantable sensor designed to deliver long-term glucose readings. Senseonics’ mission centers on improving diabetes management by providing accurate, real-time data to patients and healthcare providers.

The company’s flagship offering is the Eversense CGM System, which features a small, fully implantable sensor placed beneath the skin to measure glucose levels for up to 90 days in the United States and up to 180 days in Europe.